호흡기 질환에서의 중간엽 줄기 세포의 치료

키워드

참고문헌 (29)

1. Friedenstein AJ, "Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues", Transplantation, 6, pp.230~247 (1968)
2. Yang J, "Cell-based therapy in lung regenerative medicine", Regen Med Res, 2, pp.7~ (2014)
3. Kolios G, "Introduction to stem cells and regenerative medicine", Respiration, 85, pp.3~10 (2013)
4. Kim YI, "Cell Biological Characteristics of Adult Stem Cells", J Korean Med Assoc, 48, pp.993~1002 (2005)
5. Dominici M, "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement", Cytotherapy, 8, pp.315~317 (2006)
6. Weiss DJ, "An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases", Ann Am Thorac Soc, 12, pp.S79~S97 (2015)
7. Sueblinvong V, "Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells", Am J Respir Crit Care Med, 177, pp.701~711 (2008)
8. Mendez JJ, "Epithelial cell differentiation of human mesenchymal stromal cells in decellularized lung scaffolds", Tissue Eng Part A, 20, pp.1735~1746 (2014)
9. De Paepe ME, "Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells", Am J Pathol, 178, pp.1329~1339 (2011)
10. Loi R, "Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells", Am J Respir Crit Care Med, 173, pp.171~179 (2006)
11. Weiss DJ, "Stem cells and cell therapies in lung biology and lung diseases", Proc Am Thorac Soc, 8, pp.223~272 (2011)
12. Schweitzer KS, "Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking", Am J Respir Crit Care Med, 183, pp.215~225 (2011)
13. Prockop DJ, "Repair of tissues by adult stem", progenitor cells (MSCs): controversies, myths, and changing paradigms, 2009, pp.17, 939~946
14. Weiss DJ, "Concise review: current status of stem cells and regenerative medicine in lung biology and diseases", Stem Cells, 32, pp.16~25 (2014)
15. Stabler CT, "Mesenchymal stem cells for therapeutic applications in pulmonary medicine", Br Med Bull, 115, pp.45~56 (2015)
16. Rehman J, "Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells", Circulation, 109, pp.1292~1298 (2004)
17. Le Blanc K, "Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells", Lancet, 363, pp.1439~1441 (2004)
18. Keating A, "Mesenchymal stromal cells: new directions", Cell Stem Cell, 10, pp.709~716 (2012)
19. Prockop DJ, "Medical therapies with adult stem", pro-genitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations, 2012, pp.113, 1460~1469
20. Vestbo J, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary", Am J Respir Crit Care Med, 187, pp.347~365 (2013)
21. Ribeiro-Paes JT, "Unicentric study of cell therapy in chronic obstructive pulmonary disease", pulmonary emphysema, 2011, pp.6, 63~71
22. Weiss DJ, "A placebo-controlled, randomized trial of mesenchymal stem cells in COPD", Chest, 143, pp.1590~1598 (2013)
23. Antunes MA, "Mesenchymal stem cell trials for pulmonary diseases", J Cell Biochem, 115, pp.1023~1032 (2014)
24. ARDS Definition Task Force, "Acute respiratory distress syndrome: the Berlin Definition", JAMA, 307, pp.2526~2533 (2012)
25. Zheng G, "Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study", Respir Res, 15, pp.39~ (2014)
26. Raghu G, "An official ATS", ERS, ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, pp.Am J Respir Crit Care Med, 2011[DOI]
27. Raghu G, "An Official ATS", ERS, ALAT Clinical Practice Guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 Clinical Practice Guideline, pp.Am J Respir Crit Care Med, 2015[DOI]
28. Tzouvelekis A, "A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis", J Transl Med, 11, pp.171~ (2013)
29. Chambers DC, "A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis", Respirology, 19, pp.1013~1018 (2014)

관련 논문AI추천